Date: March 9-10, 2023 (Held preceding HTRS 2023)
Location: Orlando, Florida

FWGBD’s 2023 national colloquium on uterine hemostasis convened leading faculty, researchers, and clinicians to review their current practices and evidence-based information on the diagnosis and optimal clinical management of uterine hemostasis among women with bleeding and clotting disorders, across the lifespan.

The purpose of this meeting was to review current knowledge and practice as applied to 1) approaches to urgent bleeding events, 2) critical bleeding and clotting events through pregnancy and delivery, 3) the management of delivery for women with congenital or acquired blood disorders, with a focus on the prevention and management of postpartum hemorrhage, as well as fetal considerations at time of delivery, and 4) hematologic management through COVID.

The Colloquium Program, including learning objectives, session descriptions, and faculty bios is available for download here.

The recording and archiving of this activity was supported in part through a medical education grant from Grifols.

Thursday, March 9, 2023
Moderator: Barbara Konkle, MD

Why Is It So Hard to Measure Fibrinolysis?
Nigel Key, MB, ChB, FRCP


New Methods for Measuring Plasmin Generation: From Mice to Humans
Alisa Wolberg, PhD, FAHA

Q&A with Drs. Key and Wolberg
Lessons in Hemostasis & Thrombosis We Have Learned from COVID-19

COVID-19 and Coagulation: Michael J. Paidas, MD
Clinical Care and Guidelines: Lisa Baumann Kreuziger, MD, MS


Abortion & Contraception for Patients with Blood Disorders: A Practical Guide
Maureen K. Baldwin, MD, MPH
Kristina Haley, DO, MCR

Please contact Katherine Cantu Anguiano, Manager of Education, via email at to request recording of this content.

Friday, March 10, 2023
Moderator: Luis Pacheco, MD

C-5 inhibition of Thrombotic Microangiopathy (TMA) in Pregnancy
Richard Burwick, MD, MPH


Massive Postpartum Hemorrhage: Diagnosis & Treatment
Jason Vaught, MD


Life-Threatening Venous Thromboembolism & Pulmonary Embolism During Pregnancy
Andra H. James, MD, MPH

Q&A with Drs. Burwick, Vaught, and James

Red Blood Cell Alloimmunization
Kenneth J. Moise, Jr., MD


Fetal & Neonatal Alloimmune Thrombocytopenia (FNAIT)
Michael J. Paidas, MD

Q&A with Drs. Moise and Paidas